2019
DOI: 10.1002/mabi.201800392
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative Epigallocatechin Gallate Coating on Polymeric Substrates for Bone Tissue Regeneration

Abstract: Plant derived flavonoids have not been well explored in tissue engineering applications due to difficulties in efficient formulations with biomaterials for controlled presentation. Here, the authors report that surface coating of epigallocatechin gallate (EGCG) on polymeric substrates including poly (L‐lactic acid) (PLLA) nanofibers can be performed via oxidative polymerization of EGCG in the presence of cations, enabling regulation of biological functions of multiple cell types implicated in bone regeneration… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
25
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(25 citation statements)
references
References 59 publications
(41 reference statements)
0
25
0
Order By: Relevance
“…In this study, vhEc-GS-β containing EGCG induced more rapid resorption of the encapsulated β-TCP granules than did β-TCP alone and more osteoclasts, at least in the condition using 28 mg β-TCP. This discrepancy may be due to the different doses of EGCG; EGCG inhibits osteoclast differentiation at >20 μM [ 15 , 45 ], possibly via inhibiting the receptor activator of NF-κB ligand (RANKL) [ 46 ], whereas it promotes osteoblast differentiation, such as stem cells, from 1 to 10 μM [ 47 , 48 ]. The dose of EGCG in vhEc-GS was established based on the concentrations that significantly promote osteogenesis from previous studies [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…In this study, vhEc-GS-β containing EGCG induced more rapid resorption of the encapsulated β-TCP granules than did β-TCP alone and more osteoclasts, at least in the condition using 28 mg β-TCP. This discrepancy may be due to the different doses of EGCG; EGCG inhibits osteoclast differentiation at >20 μM [ 15 , 45 ], possibly via inhibiting the receptor activator of NF-κB ligand (RANKL) [ 46 ], whereas it promotes osteoblast differentiation, such as stem cells, from 1 to 10 μM [ 47 , 48 ]. The dose of EGCG in vhEc-GS was established based on the concentrations that significantly promote osteogenesis from previous studies [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…The results show that PLLA nanofiber does not perform well in promoting the proliferation of bone marrow mesenchymal cells, but also inhabiting the activity of RAW2.64.7 osteoclasts. Moreover, the scaffold coating EGCG can provide a proper environment for osteoblast (Madhurakkat Perikamana et al, 2019). Compared with the scaffold, not coating EGCG, nanofiber coating EGCG significantly suppress inflammation.…”
Section: Materials and Egcgmentioning
confidence: 99%
“…Nevertheless, chemical approaches coupling nanoparticles and EGCG may increase potential cytotoxicity. Some reports put out the view of EGCG coating, a form of easy physical adsorption to probably take the place of chemical approach and reduce the cytotoxicity further (Madhurakkat Perikamana et al, 2019).…”
Section: Materials and Egcgmentioning
confidence: 99%
“…Oxidative EGCG coating on polymeric substrates has been demonstrated to regulate activities of multiple cell types that are beneficial for healing of bone fractures (Madhurakkat Perikamana et al. 2019 ). However, the role of EGCG in pain management of MRF has yet to be investigated.…”
Section: Introductionmentioning
confidence: 99%